Chicago Welcomes New Leader in Clinical Science Research
As the bright lights of Chicago shine down, the University of Chicago Health System is gearing up for a fresh start with an exciting new appointment. Dr. Hedy Lee Kindler, a seasoned expert in the field of clinical trials and research, is set to take on the role of Associate Dean of Clinical Science Research starting March 1, 2025. This transition marks a significant shift in leadership, and the community couldn’t be more thrilled!
Bringing Experience and Passion
Dr. Kindler isn’t just stepping into the role with enthusiasm; she brings over 25 years of rich experience in clinical trials, particularly focused on palliative care and oncology. Her remarkable journey in medicine has made her one of the top experts globally on mesothelioma – a rare and aggressive cancer linked to asbestos exposure. She has been the driving force behind the Multidisciplinary Mesothelioma Program and has previously led the Gastrointestinal Oncology Program, establishing her reputation as a leader and innovator in her field.
A Record of Innovation
At the heart of Dr. Kindler’s work is innovation. Her research is centered around creating new clinical trials aimed at improving treatments for patients dealing with mesothelioma and pancreatic cancer. She has been instrumental in leading various national and international clinical trials that have played a key role in securing FDA approval for groundbreaking treatments. With over 220 publications in esteemed peer-reviewed journals, her work is a testament to her commitment to pushing the boundaries of medical knowledge and patient care.
A Vision for Growth
In her new position, Dr. Kindler aims to expand clinical trials throughout the University of Chicago Health System. She has an impressive background not only in conducting trials but also in understanding the complex gears that keep the clinical trials machine running. Having served on the leadership team of the Cancer Center and as Principal Investigator for the NCI National Clinical Trials Network, her expertise will be pivotal in shaping the future of clinical research at the university.
Collaborative Leadership
As the new Associate Dean, Dr. Kindler will work closely with various leaders throughout the University of Chicago’s research community. Her role is not just about overseeing trials but also ensuring that everything runs efficiently and effectively. She’ll be collaborating with leaders from clinical departments, the Pritzker School of Medicine, and partners at Advent Health to create a seamless operation, promoting synergy across different entities within the larger health system.
A Fond Farewell to Walter Stadler
Dr. Kindler takes over from Dr. Walter Stadler, a well-respected figure who held the Associate Dean position from 2019 to early 2023. Dr. Stadler played a critical role in modernizing the Office of Clinical Research and enhancing the infrastructure necessary for conducting clinical trials across the health system. His efforts laid a strong foundation that Dr. Kindler will build upon as she assumes this new leadership role.
A Bright Future
The Chicago community is buzzing with excitement about Dr. Kindler’s appointment. Her organizational skills and detail-oriented nature promise a future filled with operational excellence and patient-focused research. As she embarks on this new journey, the hope is for a vibrant evolution in clinical research that will benefit countless patients both locally and beyond.
Let’s raise our glasses to Dr. Hedy Lee Kindler and the bright future she brings to the University of Chicago Health System. Her leadership will surely be a beacon of hope for those in need of groundbreaking medical advancements!
